MesenFlow Technologies
Geneva
About MesenFlow Technologies
MesenFlow Technologies has developed a platform to meet the demands of modern drug development. It is a bio-imaging technology designed to accelerate the drug development process & provide solutions to problems associated with species cross-reactivity, animal testing & understanding human disease. This has been achieved by using proprietary protocols on primary human cells, allowing the mechanism of action & translational relevance of a drug to be defined very early on in the development process. MesenFlow Technologies has recently extended this technology for use in cosmetics and nutrition. By using their technology, it is possible to explore the physiological impact of a cosmetic or nutraceutical candidate in the early development phase. Their services are particularly tailored to business environments where animal-free testing is mandatory, and an understanding of impact on human biology is paramount.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $10.1K
- Last round: Grant (Apr 2017)
- Website: mesenflow.com
- Phone: 41 22 32 16 961
Industries & Categories
Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/mesenflow-technologies-2227136 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.